参考文献/References:
[1]郑胡镛.儿童急性淋巴细胞白血病基因学诊断分型[J].中华妇幼临床医学杂志(电子版),2014,10(3):10.[2]Cui L,Li ZG,Chai YH,et al.Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008:The first nation-wide prospective multicenter study in China[J].Am J Hematol,2018,93(7):913-920.[3]Pui CH,Yang JJ,Hunger SP,et al.Childhood acute lymphoblastic leukemia: progress through collaboration[J].Clin Oncol,2015,33(27):2938-2948.[4]丁超.核心结合因子相关急性髓系白血病的细胞和分子遗传学异常[D].苏州:苏州大学,2015.[5]Greenblatt SM,Nimer SD.Chromatin modifiers and the promise of epigenetic therapy in acute leukemia[J].Leukemia,2014,28(7):1396-1406.[6]Wang Y,Wu DP,Liu QF,et al.In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification[J].Blood: The Journal of the American Society of Hematology,2014,124(12):1880-1886.[7]Jean-Michel C,Eric J,Nicolas B,et al.Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia.[J].Blood: The Journal of the American Society of Hematology,2013,121(12):2213-2223.[8]Parker C,Waters R,Leighton C,et al.Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial[J].Lancet,2017,376(9757):2009-2017.[9]Sun W,Orgel E,Malvar J,et al.Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia[J].Pediatr Blood Cancer,2016,63(11):1943-1948.[10]范俊杰,何海龙,卢俊,等.中国儿童复发急性淋巴细胞白血病应用VDMP方案再诱导的安全性和有效性的评估——江苏小儿血液协作组报告[J].中国实验血液学杂志,2018,26(4):1033-1037.[11]Roberts KG,Li Y,Payne-Turner D,et al.Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia[J].N Engl J Med,2014,371(11):1005-1015.[12]薛玉娟,陆爱东,王毓,等.儿童pro-B急性淋巴细胞白血病的临床特点及预后分析[J].中国当代儿科杂志,2020,22(12):1286-1294.[13]Maude SL,Tasian SK,Vincent T,et al.Targeting JAK1/2 and m TOR in murine xenograft models of Ph-like acute lymphoblastic leukemia[J].Blood,2012,120(17):3510-3518.[14]Lee DW,Stetler-Stevenson M,Yuan CM,et al.Safety and response of incorporating CD19 chimeric antigen receptor T cell therapy in typical salvage regimens for children and young adults with acute lymphoblastic leukemia[J].Blood,2015,126(23):684.[15]Lee DW,Kochenderfer JN,Stetler-Stevenson M,et al.T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukemia in children and young adults: a phase 1 dose-escalation trial[J].Lancet,2015,385(9967):517-528.[16]Dai H,Wang Y,Lu X,et al.Chimeric antigen receptors modified T-cells for cancer therapy[J].J Natl Cancer Inst,2016,108(7):1507-1517.[17]程玉才,黄礼彬,王丽娜,等.miRNA 表达谱改变与儿童急性淋巴细胞白血病复发的相关性[J].中山大学学报(医学科学版),2014,35(5):717-722.
相似文献/References:
[1]黄倩云,李长钢.门冬酰胺酶对白血病患儿静脉血栓形成的研究进展[J].医学信息,2018,31(12):39.[doi:10.3969/j.issn.1006-1959.2018.12.013]
HUANG Qian-yun,LI Chang-gang.Advances in the Treatment of Venous Thrombosis in Children with Leukemia by Asparaginase[J].Medical Information,2018,31(20):39.[doi:10.3969/j.issn.1006-1959.2018.12.013]
[2]金 英.甲磺酸伊马替尼对难治性Ph染色体阳性急性淋巴细胞白血病患者免疫功能及生存率的影响[J].医学信息,2022,35(13):139.[doi:10.3969/j.issn.1006-1959.2022.13.033]
JIN Ying.Effect of Imatinib Mesylate on Immune Function and Survival Rate in Patients with Refractory Ph Chromosome Positive Acute Lymphoblastic Leukemia[J].Medical Information,2022,35(20):139.[doi:10.3969/j.issn.1006-1959.2022.13.033]
[3]韩怡波.儿童急淋大剂量甲氨蝶呤延迟解救的安全性研究[J].医学信息,2019,32(19):143.[doi:10.3969/j.issn.1006-1959.2019.19.046]
HAN Yi-bo.Safety Study on Delayed Rescue of High-Dose Methotrexate in Children[J].Medical Information,2019,32(20):143.[doi:10.3969/j.issn.1006-1959.2019.19.046]
[4]杨月琴,叶中绿.儿童急性淋巴细胞白血病早期治疗反应对预后价值的研究[J].医学信息,2020,33(04):51.[doi:10.3969/j.issn.1006-1959.2020.04.016]
YANG Yue-qin,YE Zhong-lv.Study on Early Prognostic Value of Childhood Acute Lymphoblastic Leukemia in Response to Treatment[J].Medical Information,2020,33(20):51.[doi:10.3969/j.issn.1006-1959.2020.04.016]
[5]刘婕妤,方智辉,李文克,等.复方磺胺甲噁唑对急性淋巴细胞白血病化疗后肺孢子菌肺炎的预防作用[J].医学信息,2020,33(12):135.[doi:10.3969/j.issn.1006-1959.2020.12.042]
LIU Jie-yu,FANG Zhi-hui,LI Wen-ke,et al.Preventive Effect of Compound Sulfamethoxazole on Pneumocystis Pneumonia After Chemotherapy in Acute Lymphoblastic Leukemia[J].Medical Information,2020,33(20):135.[doi:10.3969/j.issn.1006-1959.2020.12.042]